← Browse by Condition
Medical Condition

high risk smoldering multiple myeloma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05469893 Phase 2
Recruiting

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

Enrollment
52 pts
Location
United States
Sponsor
Irene Ghobrial, MD
View Trial →